دواعي استعمال راسيكاروكس 10مجم/جم اكياس
معلومات من نشرات دوائية ومراجع موثقة، مع مصدر كل معلومة. السعر الحالي: 5ج.م.
دواعي الاستعمال
- Complementary symptomatic treatment of acute diarrhoea in infants older than 3 months and children, together with oral rehydration, when rehydration alone is insufficient and causal treatment is not possibleالفئة: Infants older than 3 months and children (<13 kg for the 10 mg sachet)Health Products Regulatory Authority (HPRA)
الآثار الجانبية
- Common: headache. Uncommon: rash, erythema. Frequency unknown: erythema multiforme, angioedema and facial/lip/tongue/eyelid oedema, urticaria, pruritus, DRESS, anaphylactic shock.نشرة دولية لتركيبة مكافئة · Health Products Regulatory Authority (HPRA)
موانع الاستعمال
- Hypersensitivity to racecadotril or any excipient.نشرة دولية لتركيبة مكافئة · Health Products Regulatory Authority (HPRA)
- Contains sucrose: contraindicated in hereditary fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase deficiency (Irish product excipient; Egyptian excipients not confirmed).نشرة دولية لتركيبة مكافئة · Health Products Regulatory Authority (HPRA)
تحذيرات واحتياطات
- Racecadotril does not modify usual rehydration regimens; rehydration remains essential.نشرة دولية لتركيبة مكافئة · Health Products Regulatory Authority (HPRA)
- Do not use with bloody or purulent stools and fever (possible invasive bacterial infection) or in antibiotic-associated diarrhoea; chronic diarrhoea not sufficiently studied.نشرة دولية لتركيبة مكافئة · Health Products Regulatory Authority (HPRA)
- Angioedema (allergic or bradykinin-mediated) may occur; stop treatment, supervise until resolution and do not reintroduce. Careful risk/benefit assessment needed with ACE inhibitors.نشرة دولية لتركيبة مكافئة · Health Products Regulatory Authority (HPRA)
- Skin reactions, sometimes severe, and severe cutaneous adverse reactions including DRESS have been reported; withdraw immediately if DRESS is suspected and never restart.نشرة دولية لتركيبة مكافئة · Health Products Regulatory Authority (HPRA)
التداخلات الدوائية
- ACE inhibitors and other drugs causing bradykinin-mediated angioedema (e.g. angiotensin II antagonists, gliptins, mTOR inhibitors, sacubitril)Concomitant use may increase the risk of angioedema and is not recommended.Health Products Regulatory Authority (HPRA)
الحمل والرضاعة
- No adequate human data; animal studies show no harmful effects, but racecadotril should not be given to pregnant women.نشرة دولية لتركيبة مكافئة · Health Products Regulatory Authority (HPRA)
- Excretion in human milk unknown; should not be given to breastfeeding women.نشرة دولية لتركيبة مكافئة · Health Products Regulatory Authority (HPRA)
المصادر
- السعر: قوائم أسعار الأدوية المنشورة في مصر.
- Health Products Regulatory Authority (HPRA)
- WHO Collaborating Centre for Drug Statistics Methodology